Advances in the Treatment of Cardiac Amyloidosis
(2020)
Advances in the Treatment of Cardiac Amyloidosis: pp.
-.
Chapter 2
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin‑mediated amyloidosis